Global Brain PET-MRI Systems Market Analysis

The Global Brain PET-MRI Systems Market stood at around xx Bn in 2023 and is projected to reach US $xx Bn by 2033, exhibiting a CAGR of xx% during the forecast period.

The Global Brain PET-MRI Systems Market Analysis Executive Summary

A brain positron emission tomography scan is a diagnostic x-ray of the brain. It employs a component known as a tracer, which is radioactive, in its attempt to find disease or injury in the brain. A PET scan reveals how the brain and its tissue’s function. Other imaging tests like magnetic resonance imaging and computed axial tomography provide only the structural depiction of the brain and the tissue surrounding it. According to the Lancet Neurology, over 3 billion people globally are suffering from a neurological disorder in 2021.

The Brain PET-MRI Systems market is growing at a rapid pace owing to the rise in the number of neurological disorders, development of imaging systems and an increase in research and development activities. This market consists of integrated PET-MRI, and solo PET-MRI systems for oncology, neurology, and psychiatry fields, with the highest demand in North America and Europe. Nevertheless, there is evidence of risks and limitations, such as high costs and technical feasibility. It is dominated by players like Siemens Healthineers, GE Healthcare, Philips Healthcare, and is also expected to expand as several new technologies and applications are discovered. 

Global Brain PET-MRI Systems Market Dynamics

Market Growth Drivers

The brain PET-MRI systems market is expected to expand due to the increasing number of patients with neurological disorders that require better imaging solutions such as Alzheimer and Parkinson diseases. Advances in PET-MRI technologies are improving reconnaissance while the inclination of individuals towards more personalized treatment is paving the way for better imagines. More and more research in this area, rising awareness among the healthcare providers, and a favourable regulatory landscape also contribute to the market growth, with PET-MRI systems being employed in clinical and research use across different branches of medicine. 

Opportunity

The opportunities for the development of brain PET-MRI systems in the future include the extension of the role of the method other than neurological disorders, cancer, and cardiovascular diseases, and the use of whole-body imaging. The development of the technology can allow for its use in diagnosing more complex diseases in the future. Moreover, the shift towards more precise and individualized treatments also creates new demand for PET-MRI systems in precise patient-specific approaches. Asia pacific, Latin America and Middle eastern countries are the most likely markets for the company to expand to because with improvement in healthcare, awareness for these technologies will rise. 

Market Restraints

There are several obstacles to adopting brain PET-MRI systems, one of the biggest being that acquiring a system costs millions, which makes it difficult for small institutions. The difficulties of installation and maintenance increase further, as it demands professional knowledge and more assets. In other areas, limited reimbursement also impacts the ability to invest in these systems; concerns over radiation exposure in general and particularly for women may also affect the use of these technologies. Further, other imaging modalities and scarcity of knowledge and expertise in healthcare professionals also poses challenges to the integration of these efficient hybrid systems. 

Competitive Landscape Brain PET-MRI Systems Market in Global

Key Players

• Siemens Healthineers AG
• Koninklijke Philips N.V.
• General Electric (GE) Co. (GE Healthcare)
• Bruker Corporation
• Mediso Ltd.
• MR Solutions Group
• Cubresa, Inc.

Recent Developments

July 2024, Positrigo Received FDA Clearance for Breakthrough Brain PET System. The Food and Drug Administration (FDA) has granted 510(k) clearance for the NeuroLF system, which offers dedicated positron emission tomography (PET) imaging of the brain.

February 2024, Philips introduced Smart Quant Neuro 3D, an AI-based quantitative brain imaging tool for MRI. This newly launched product provides healthcare providers with advanced tools to enhance diagnostic confidence.

August 2023, First India-made MRI scanner to be launched for clinical work. The indigenously developed machine is characterised by several innovations, including avoiding reliance on scarcely available liquid helium, bottom-up software design, and customised hardware.

May 2023, Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute. The Cubresa BrainPET is a removeable, high-performing PET scanner, specifically designed for PET/MRI brain imaging.

Mergers and Acquisitions

July 2024, GE HealthCare to acquire AI business from ultrasound firm for $51M, plus more vendor news.

January 2021, GE Healthcare acquires Prismatic Sensors and its advanced photon-counting CT sensors.

Healthcare Policies and Regulatory Landscape for Brain PET-MRI Systems Market in Global

Policy changes and Reimbursement scenario

Revolutionary elements in healthcare practices such as the FDA are authorizing more health brain PET-MRI products to ensure that healthcare givers offer enhanced diagnostics to their patients. Out of the observed trends in the field of brain PET-MRI systems, governments are working towards enhancing the policy landscape. In the United States, in early 2020, the CMS increased reimbursement for amyloid PET scans for early diagnosis of Alzheimer’s disease. There are checks in place for the use of brain pet MRI as professional medical societies are coming up with correct and suitable use. However, reimbursement is still a worry, with only very restricted prospects for neurological use in many areas while countries like Japan are expanding the incidence of coverage for diseases like Parkinson’s. Costs are less of an issue for research use, as reimbursement can be requested through grants, however, high costs remain a major concern for clinical use in certain countries.